TrialDiabetes, obesity & metabolism2025

Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6.

Jingmin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.